
Angion Biomedica Corp. – NASDAQ:ANGN
Angion Biomedica Corp. stock price monthly change
Angion Biomedica Corp. stock price quarterly change
Angion Biomedica Corp. stock price yearly change
Angion Biomedica Corp. key metrics
Market Cap | 30.11M |
Enterprise value | N/A |
P/E | -0.37 |
EV/Sales | -13.93 |
EV/EBITDA | 0.86 |
Price/Sales | 6.39 |
Price/Book | 0.33 |
PEG ratio | -0.01 |
EPS | -4.24 |
Revenue | N/A |
EBITDA | -23.75M |
Income | -34.19M |
Revenue Q/Q | N/A |
Revenue Y/Y | -100% |
Profit margin | -1686.53% |
Oper. margin | -1463.62% |
Gross margin | 0% |
EBIT margin | -1463.62% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAngion Biomedica Corp. stock price history
Angion Biomedica Corp. stock forecast
Angion Biomedica Corp. financial statements
Dec 2022 | 0 | -11.51M | |
---|---|---|---|
Mar 2023 | 0 | -4.46M | |
Jun 2023 | 0 | -7.55M | |
Sep 2023 | 0 | -10.65M |
2023-08-21 | 0.57 | -2.43763 |
---|
Dec 2022 | 52790000 | 9.01M | 17.08% |
---|---|---|---|
Mar 2023 | 41767000 | 2.10M | 5.03% |
Jun 2023 | 37619000 | 14.06M | 37.38% |
Sep 2023 | 30987000 | 17.70M | 57.12% |
Jun 2022 | -9.90M | 0 | -14K |
---|---|---|---|
Sep 2022 | -8.40M | 0 | -17K |
Dec 2022 | -4.42M | 0 | -15K |
Mar 2023 | -8.07M | -10M | -3.26M |
Angion Biomedica Corp. alternative data
Aug 2023 | 3 |
---|---|
Sep 2023 | 3 |
Oct 2023 | 3 |
Nov 2023 | 3 |
Dec 2023 | 3 |
Jan 2024 | 3 |
Feb 2024 | 3 |
Mar 2024 | 3 |
Apr 2024 | 3 |
May 2024 | 3 |
Jun 2024 | 3 |
Jul 2024 | 3 |
Angion Biomedica Corp. other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 1213000 | 0 |
Insider | Compensation |
---|---|
Ms. Jennifer J. Rhodes J.D. (1970) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. | $500,000 |
Dr. Jay R. Venkatesan M.B.A., M.D., Ph.D. (1972) Pres, Chief Executive Officer & Director | $390,000 |
Mr. Gregory S. Curhan (1962) Interim Chief Financial Officer | $359,010 |
-
When is Angion Biomedica Corp.'s next earnings date?
Unfortunately, Angion Biomedica Corp.'s (ANGN) next earnings date is currently unknown.
-
Does Angion Biomedica Corp. pay dividends?
No, Angion Biomedica Corp. does not pay dividends.
-
How much money does Angion Biomedica Corp. make?
Angion Biomedica Corp. has a market capitalization of 30.11M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 91.87% to 2.3M US dollars. Angion Biomedica Corp. made a loss 55.7M US dollars in net income (profit) last year or -$2.44 on an earnings per share basis.
-
What is Angion Biomedica Corp.'s stock symbol?
Angion Biomedica Corp. is traded on the NASDAQ under the ticker symbol "ANGN".
-
What is Angion Biomedica Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Angion Biomedica Corp.?
Shares of Angion Biomedica Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Angion Biomedica Corp.'s key executives?
Angion Biomedica Corp.'s management team includes the following people:
- Ms. Jennifer J. Rhodes J.D. Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.(age: 55, pay: $500,000)
- Dr. Jay R. Venkatesan M.B.A., M.D., Ph.D. Pres, Chief Executive Officer & Director(age: 53, pay: $390,000)
- Mr. Gregory S. Curhan Interim Chief Financial Officer(age: 63, pay: $359,010)
-
How many employees does Angion Biomedica Corp. have?
As Jul 2024, Angion Biomedica Corp. employs 3 workers.
-
When Angion Biomedica Corp. went public?
Angion Biomedica Corp. is publicly traded company for more then 4 years since IPO on 5 Feb 2021.
-
What is Angion Biomedica Corp.'s official website?
The official website for Angion Biomedica Corp. is angion.com.
-
Where are Angion Biomedica Corp.'s headquarters?
Angion Biomedica Corp. is headquartered at 51 Charles Lindbergh Boulevard, Uniondale, NY.
-
How can i contact Angion Biomedica Corp.?
Angion Biomedica Corp.'s mailing address is 51 Charles Lindbergh Boulevard, Uniondale, NY and company can be reached via phone at +41 56554899.
Angion Biomedica Corp. company profile:

Angion Biomedica Corp.
angion.comNASDAQ
3
Biotechnology
Healthcare
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
Uniondale, NY 11553
CIK: 0001601485
ISIN: US03476J1079
CUSIP: 03476J107